Genevant, Arbutus Biopharma Sue Moderna for Patent Infringement

Genevant Sciences and Arbutus Biopharma say they have filed a patent infringement lawsuit in the U.S. District Court for the District of Delaware against Moderna and an affiliate regarding the manufacture and sale of Moderna’s Covid-19 vaccine.

• Patents relate to nucleic acid-lipid particles and lipid vesicles, as well as compositions and methods for their use
• Genevant and Arbutus say they do not seek to impede the sale, manufacture or distribution of Moderna’s Covid vaccine
• Companies say Moderna has previously initiated inter partes review challenges against patents in 2018 and 2019 and has also had an appeal rejected by the United ...